One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Effect of a Community-Based Medical Oncology Depression Screening Program on Behavioral Health Referrals Among Patients With Breast CancerA Randomized Clinical Trial
Erin E. Hahn, PhD, MPH; Corrine E. Munoz-Plaza, MPH; Dana Pounds, MS; et al.
doi : 10.1001/jama.2021.22596
Effect of Regional vs General Anesthesia on Incidence of Postoperative Delirium in Older Patients Undergoing Hip Fracture SurgeryThe RAGA Randomized Trial
Ting Li, PhD; Jun Li, PhD; Liyong Yuan, MD; et al.
doi : 10.1001/jama.2021.22647
Association Between Maternal Hormonal Contraception Use and Central Nervous System Tumors in Children
Marie Hargreave, PhD; Lina S. Mørch, PhD; Jeanette F. Winther, DMSc; et al.
doi : 10.1001/jama.2021.22482
Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older
Marie Joelle Jabagi, PharmD, PhD; Jérémie Botton, PharmD, PhD; Marion Bertrand, MSc; et al.
doi : 10.1001/jama.2021.21699
Medicare Advantage for AllA Potential Path to Universal Coverage
Greg J. Zahner, MD, MSc; Peter W. Croughan, MD; Daniel M. Blumenthal, MD, MBA
doi : 10.1001/jama.2021.23329
Treating the Most Critically Ill Patients With COVID-19The Evolving Role of Extracorporeal Membrane Oxygenation
Graeme MacLaren, MBBS, MSc; Dale Fisher, MBBS; Daniel Brodie, MD
doi : 10.1001/jama.2021.22580
Applying Syndemic Theory to Acute Illness
Kristina E. Rudd, MD, MPH; Christina F. Mair, PhD, MPH; Derek C. Angus, MD, MPH
doi : 10.1001/jama.2021.22583
General Anesthesia and Postoperative Neurocognitive Outcomes
Michael S. Avidan, MBBCh; Elizabeth L. Whitlock, MD, MS; George A. Mashour, MD, PhD
doi : 10.1001/jama.2021.22465
Maternal Contraceptive Use and Central Nervous System Tumors in Offspring
Logan G. Spector, PhD; Christopher L. Moertel, MD; H. Irene Su, MD, MSCE
doi : 10.1001/jama.2021.21809
How to Use and Interpret the Results of a Platform TrialUsers’ Guide to the Medical Literature
Jay J. H. Park, PhD; Michelle A. Detry, PhD; Srinivas Murthy, MD, CM, MHSc; et al.
doi : 10.1001/jama.2021.22507
Phenome-Wide Association Studies
Lisa Bastarache, MS; Joshua C. Denny, MD, MS; Dan M. Roden, MD
doi : 10.1001/jama.2021.20356
Severe Polyarthralgia After Kidney Transplant
Nur Azizah Allameen, MBBS, MMed; Jiacai Cho, MBBS, MMed
doi : 10.1001/jama.2021.18866
Why Parents Still Hesitate to Vaccinate Their Children Against COVID-19
Melissa Suran, PhD, MSJ
doi : 10.1001/jama.2021.21625
Belief in Having Had COVID-19 Linked With Long COVID Symptoms
Anita Slomski
doi : 10.1001/jama.2021.23318
Novel Study Tests n-of-1 Trials for Atrial Fibrillation Triggers
Anita Slomski
doi : 10.1001/jama.2021.23319
Lighting the Way for Improved Detection of Ovarian Cancer
Rebecca Voelker, MSJ
doi : 10.1001/jama.2021.22960
A Treatment Advance for Patients With Posttransplant CMV
Rebecca Voelker, MSJ
doi : 10.1001/jama.2021.23423
The COVID-19 Pandemic in Serial Medical Dramas
Irene Cambra-Badii, PhD; Elena Guardiola, MD, PhD; Josep-E. Baños, MD, PhD
doi : 10.1001/jama.2021.19779
Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation Effect on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure
Stephen Derdak, DO
doi : 10.1001/jama.2021.21002
Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation Effect on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure
Andriy Batchinsky, MD; Teryn Roberts, PhD; Leopoldo Cancio, MD
doi : 10.1001/jama.2021.20999
Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation Effect on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure
Ravindranath Tiruvoipati, PhD; Giles Peek, MD
doi : 10.1001/jama.2021.20996
Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation Effect on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure—Reply
James J. McNamee, MB, ChB; Daniel Brodie, MD; Daniel F. McAuley, MD
doi : 10.1001/jama.2021.21005
Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease
Steven J. Frucht, MD
doi : 10.1001/jama.2021.21008
Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease—Reply
Eric A. Macklin, PhD; Alberto Ascherio, MD, DrPH; Michael A. Schwarzschild, MD, PhD
doi : 10.1001/jama.2021.21011
